Clinical Trials
141 trialsPET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
National Institutes of Health Clinical Center (CC)
Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors
National Cancer Institute (NCI)
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene
National Cancer Institute (NCI)
Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy
National Cancer Institute (NCI)
Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C
National Cancer Institute (NCI)
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
National Cancer Institute (NCI)
Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors
National Cancer Institute (NCI)
17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Bevacizumab and Sunitinib in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Sorafenib in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
National Cancer Institute (NCI)
Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
National Cancer Institute (NCI)
Dietary Soy Isoflavones for the Prevention of Cancer
National Cancer Institute (NCI)
Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Irinotecan in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
PNU 166148 in Treating Patients With Metastatic Solid Tumors
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
CP-609,754 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
National Cancer Institute (NCI)
Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
National Cancer Institute (NCI)
3-AP in Treating Patients With Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery
National Cancer Institute (NCI)
SJG-136 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
AFP464 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Vinorelbine in Treating Patients With Metastatic or Advanced Solid Tumors
National Cancer Institute (NCI)
GW786034 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations
National Cancer Institute (NCI)
An Individualized Internet-Based Health Behavior Program or a Standard Internet-Based Health Behavior Program in Preventing Cancer and Improving Physical Activity and Nutrition in Participants Who Are Physically Inactive With a Higher Body Mass Index
National Cancer Institute (NCI)
Promoting Physical Activity In After-School Programs for Urban Adolescents
National Cancer Institute (NCI)
Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet
National Cancer Institute (NCI)
Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer
National Cancer Institute (NCI)